Azitra AZTR
NYSE AZTR
$0.14 +0.01 (+4.13%)
As of: Sep 30, 2026 · 3:51 PM EDT

Azitra (AZTR) Capital Leases (2023 - 2025)

Updated

Azitra's Capital Leases came in at $1,479 for Q2 2025, down 91.9% from $18,329 a year earlier and down 74.7% from the prior quarter.

Analysis

Azitra (AZTR) Capital Leases (2023 - 2025) Analysis & Trends

At the end of FY2024, Azitra's Capital Leases was $10,105, down 61.4% from FY2023.

  • Going back by year, Capital Leases was $26,169 in FY2023.
  • The Q2 2025 figure represents the lowest quarterly Capital Leases in data going back to Q3 2023.
  • Year-over-year, Capital Leases has declined for four consecutive quarters, with an average decline of 69.9% over the last four quarters.
  • Business Quant data shows AZTR's Capital Leases at $5,843 (Q1 2025), $10,105 (Q4 2024) and $14,266 (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Azitra 2.51 Mn 2.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1,479.00
Mar 31, 2025 5,843.00
Dec 31, 2024 10,105.00
Sep 30, 2024 14,266.00
Jun 30, 2024 18,329.00
Mar 31, 2024 22,296.00
Dec 31, 2023 26,169.00
Sep 30, 2023 29,952.00
API Access

Azitra Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=AZTR&period=max&api_key=YOUR_API_KEY